ArticleFrontiers in immunology2021

Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.

Jinghong Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.